[1] HUANG L, ZHAO Z, WEN J, et al. Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review). Mol Med Rep. 2020; 22(3):2155-2162.
[2] 朱兰, 陈娟. 《盆腔器官脱垂的中国诊治指南(2020年版)》解读[J]. 中华医学信息导报,2020,35(15):17.
[3] YIN Y, HAN Y, SHI C, et al. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse. Open Med (Wars). 2020;15(1):833-840.
[4] DIEDRICH CM, ROOVERS J, SMIT TH, et al. Fully absorbable poly-4-hydroxybutyrate implants exhibit more favorable cell-matrix interactions than polypropylene. Materi Sci Eng C Mater Biol Appl. 2021;120:111702.
[5] QUINN JJ, CHANG HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47-62.
[6] 张志磊, 赵冰, 刘灵, 等. 盆底器官脱垂疾病mRNA和lncRNA差异表达谱的综合分析[J]. 郑州大学学报(医学版),2020,55(2):236-242.
[7] PALCAU AC, CANU V, DONZELLI S, et al. CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals. Molecular Cancer. 2022;21(1):33.
[8] HU HH, CHEN DQ, WANG YN, et al. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76-83.
[9] LIU N, FENG J, LU X, et al. Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-beta1/Smad3 and TGF-beta1/p38 MAPK Pathways. Mediators Inflamm. 2019;2019:6175091.
[10] ZHANG Q, CHANG X, WANG H, et al. TGF-beta1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro. Environ Toxicol. 2020;35(4):419-429.
[11] ZHANG X, FENG W, ZHANG J, et al. Long noncoding RNA PVT1 promotes epithelialmesenchymal transition via the TGFbeta/Smad pathway in pancreatic cancer cells. Oncol Rep. 2018;40(2):1093-1102.
[12] RAJU R, LINDER BJ. Evaluation and Management of Pelvic Organ Prolapse. Mayo Clin Proc. 2021;96(12):3122-3129.
[13] REN S, XIE B, WANG J, et al. Biomechanics of pelvic organ prolapse. Sci China Life Sci. 2015;58(2):218-220.
[14] WEINTRAUB AY, GLINTER H, MARCUS-BRAUN N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020;46(1):5-14.
[15] EL MH, LOEUILLARD E, LEMOINNE S, et al. Culture Model of Rat Portal Myofibroblasts. Front Physiol. 2016;7:120.
[16] CANALS J, NAVARRO A, VILA C, et al. Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines. J Exp Clin Cancer Rese. 2022;41(1):37.
[17] WANG D, HU Y. Long Non-coding RNA PVT1 Competitively Binds MicroRNA-424-5p to Regulate CARM1 in Radiosensitivity of Non-Small-Cell Lung Cancer. Mol Ther Nucleic Acids. 2019;16:130-140.
[18] CHEN J, YU Y, LI H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.
[19] LI Y, SUN W, PAN H, et al. LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1. Ecotoxicol Environ Saf. 2021; 213:112030.
[20] CAO F, LI Z, DING W, et al. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation. Mol Med. 2019; 25(1):7.
[21] MARTINOTTI S, RANZATO E. Scratch Wound Healing Assay. Methods Mol Biol. 2020;2109:225-229.
[22] MCKINNON KM. Flow Cytometry: An Overview. Curr Protoc Immunol. 2018;120:1-5.
[23] WANG J, KONG X, HU H, et al. Knockdown of long non-coding RNA PVT1 induces apoptosis of fibroblast-like synoviocytes through modulating miR-543-dependent SCUBE2 in rheumatoid arthritis. J Orthop Surg Res. 2020;15(1):142.
[24] ZHENG J, YU F, DONG P, et al. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152. Oncotarget. 2016;7(39):62886-62897.
[25] NEVZOROVA YA, CUBERO FJ, HU W, et al. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. J Hepatol. 2016;64(3):628-640.
[26] FEGHALI CA, BOULWARE DW, FERRISS JA, et al. Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity. 1993;16(3):167-171.
[27] QIN H, TANG Y, MAO Y, et al. C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1. Cellular Signalling. 2022;93:110274.
[28] ZHOU Z, NI J, LI J, et al. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice. J Mol Med (Berl). 2020; 98(4):527-540.
[29] ZHANG N, SUN Y. LncRNA ROR facilitates myocardial fibrosis in rats with viral myocarditis through regulating C-Myc expression. Eur Rev Med Pharmacol Sci. 2019;23(24):10982-10988.
[30] JIN K, WANG S, ZHANG Y, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76(21):4275-4289.
[31] TSENG YY, MORIARITY BS, GONG W, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512(7512):82-86.
[32] GHADIRI A, SHARIFI M, MEHRZAD V, et al. Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1. Clin Transl Oncol. 2020;22(11):2103-2110.
[33] SHIGEYASU K, TODEN S, OZAWA T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer. 2020;19(1):155.
[34] LIAN N, LI T. Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications. Biomed Pharmacother. 2016;84:42-50.
[35] 石永英, 卢俊江, 陈广原, 等. p15与c-Myc在TGF-β1诱导的大鼠心肌细胞肥大中的表达及与TGF/Smad信号通路的关系[J]. 中国动脉硬化杂志,2018,26(3):245-252.
[36] 刘红艳, 齐创. 萝卜硫素调控TGF-β1/Smad信号通路抑制结肠癌HT-29细胞增殖的机制研究[J]. 蚌埠医学院学报,2020,45(3):311-314.
[37] HU L, LIU J, LI Z, et al. Transforming growth factor-beta1 activates DeltaNp63/c-Myc to promote oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(4):460-482.
[38] 郝淑玲, 王卫平, 李建东, 等. 肾上腺髓质素和转化生长因子β1对肺成纤维细胞增殖及c-myc表达的影响[J]. 中华实用诊断与治疗杂志,2015,29(4):333-335.
|